HIV Rapid Screening Test (NHC Offer)

The HIV Rapid Screening Test (NHC Offer) is a blood test used to screen for Human Immunodeficiency Virus (HIV) infection, the virus that can lead to Acquired Immunodeficiency Syndrome (AIDS) if left untreated. This rapid screening test is performed using the Immunochromatography method, providing a quick and reliable initial assessment for HIV infection. It is designed to detect HIV infection at an early stage and support timely medical evaluation.

The HIV Rapid Screening Test is recommended for individuals with possible HIV exposure, those with high-risk behaviors, pregnant women, blood donors, healthcare workers after occupational exposure, and anyone advised by a healthcare provider. The test is highly sensitive and is intended as a screening test, not a definitive diagnosis. According to NACO (National AIDS Control Organisation) guidelines, any reactive (positive) sample is further tested using three different methods before the final report is issued, and reactive results should be confirmed with a Western Blot test or other approved confirmatory testing, as per current clinical protocols. Early detection of HIV enables timely treatment, reduces the risk of disease progression, and helps prevent transmission of the virus. Test results should always be interpreted by a qualified healthcare professional in conjunction with confirmatory testing and clinical evaluation.